HK2 is an essential enzyme for glycolysis, which has been elaborated to be targeted by the LncRNA DANCR/miR-125b-5p axis involved in regulating the glucose metabolism of CRC cells and inducing cisplatin resistance [159]. The gene discussed is HK2; the disease is colorectal carcinoma.